Researchers looked at the records of 356,958 veterans with post-traumatic stress disorder and found that majority of them were given psychiatric drugs not supported by guidelines developed by the Department of Veterans Affairs and the Department of Defense. Data showed that 65.7% of veterans were given selective serotonin-norepinephrine reuptake inhibitors, while 37% and 25.6% were prescribed benzodiazepines and second-generation antipsychotic medications, respectively. The study appeared in the journal Psychiatric Services.

Related Summaries